PFM Health Sciences’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-60,776
| Closed | -$19.6M | – | 85 |
|
|
2025
Q3 | $19.6M | Buy |
+60,776
| New | +$18.9M | 1.51% | 20 |
|
|
2025
Q2 | – | Sell |
-88,222
| Closed | -$38.4M | – | 65 |
|
|
2025
Q1 | $38.4M | Buy |
+88,222
| New | +$35.4M | 2.79% | 12 |
|
|
2024
Q4 | – | Sell |
-56,441
| Closed | -$29.3M | – | 93 |
|
|
2024
Q3 | $29.3M | Buy |
56,441
+1,191
| +2% | +$636K | 1.66% | 20 |
|
|
2024
Q2 | $29.9M | Hold |
55,250
| – | – | 1.48% | 25 |
|
|
2024
Q1 | $28.6M | Buy |
55,250
+7,569
| +16% | +$3.76M | 1.35% | 28 |
|
|
2023
Q4 | $22.5M | Buy |
47,681
+23,150
| +94% | +$10.7M | 1.35% | 27 |
|
|
2023
Q3 | $10.7M | Sell |
24,531
-50,591
| -67% | -$22.9M | 0.5% | 54 |
|
|
2023
Q2 | $33.4M | Buy |
75,122
+42,539
| +131% | +$19.6M | 1.3% | 35 |
|
|
2023
Q1 | $15M | Sell |
32,583
-34,532
| -51% | -$16.4M | 0.66% | 51 |
|
|
2022
Q4 | $34.4M | Buy |
67,115
+41,315
| +160% | +$21M | 1.23% | 34 |
|
|
2022
Q3 | $11.7M | Sell |
25,800
-16,934
| -40% | -$8.1M | 0.42% | 60 |
|
|
2022
Q2 | $20.6M | Hold |
42,734
| – | – | 0.79% | 48 |
|
|
2022
Q1 | $21M | Hold |
42,734
| – | – | 0.79% | 44 |
|
|
2021
Q4 | $19.8M | Buy |
+42,734
| New | +$18M | 0.67% | 49 |
|
|
2021
Q1 | – | Sell |
-164,238
| Closed | -$52.7M | – | 96 |
|
|
2020
Q4 | $52.7M | Buy |
164,238
+60,783
| +59% | +$18.7M | 1.86% | 18 |
|
|
2020
Q3 | $27.8M | Buy |
103,455
+3,455
| +3% | +$930K | 1.28% | 28 |
|
|
2020
Q2 | $26.3M | Sell |
100,000
-123,925
| -55% | -$33.1M | 1.36% | 30 |
|
|
2020
Q1 | $50.8M | Buy |
223,925
+25,377
| +13% | +$6.92M | 4.18% | 3 |
|
|
2019
Q4 | $60M | Buy |
+198,548
| New | +$54.6M | 2.86% | 10 |
|
|
2019
Q3 | – | Sell |
-189,219
| Closed | -$53.4M | – | 80 |
|
|
2019
Q2 | $53.4M | Sell |
189,219
-157,178
| -45% | -$42.9M | 1.01% | 36 |
|
|
2019
Q1 | $99.4M | Sell |
346,397
-105,024
| -23% | -$30.4M | 2.2% | 11 |
|
|
2018
Q4 | $119M | Sell |
451,421
-80,269
| -15% | -$22.1M | 3.15% | 3 |
|
|
2018
Q3 | $146M | Sell |
531,690
-175,554
| -25% | -$45.6M | 2.13% | 6 |
|
|
2018
Q2 | $168M | Buy |
707,244
+46,374
| +7% | +$10.7M | 2.64% | 6 |
|
|
2018
Q1 | $145M | Buy |
660,870
+393,065
| +147% | +$92.3M | 2.95% | 6 |
|
|
2017
Q4 | $60.3M | Sell |
267,805
-364,516
| -58% | -$77.6M | 1.43% | 29 |
|
|
2017
Q3 | $120M | Buy |
632,321
+77,005
| +14% | +$14.7M | 2.36% | 6 |
|
|
2017
Q2 | $104M | Buy |
555,316
+115,190
| +26% | +$20.7M | 2.81% | 5 |
|
|
2017
Q1 | $72.8M | Sell |
440,126
-96,331
| -18% | -$15.3M | 1.82% | 18 |
|
|
2016
Q4 | $77.1M | Buy |
+536,457
| New | +$71.8M | 2.17% | 15 |
|
|
2016
Q2 | – | Sell |
-518,909
| Closed | -$72.1M | – | 88 |
|
|
2016
Q1 | $72.1M | Buy |
+518,909
| New | +$69.3M | 2.22% | 18 |
|
|
2015
Q3 | – | Sell |
-513,715
| Closed | -$84.3M | – | 86 |
|
|
2015
Q2 | $84.3M | Buy |
+513,715
| New | +$82.1M | 2.13% | 14 |
|
Other funds holding ELV
PFM Health Sciences's ELV Position: Q4 2025 in Review
PFM Health Sciences sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 60,776 shares — an estimated $19.6M sold.
PFM Health Sciences first reported a position in ELV in Q2 2015 and held it in 32 quarters. The position peaked at $168M in Q2 2018. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.
- PFM Health Sciences reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
- PFM Health Sciences sold 60,776 Elevance Health shares in Q4 2025, an estimated $19.6M.
- PFM Health Sciences first reported a position in Elevance Health in Q2 2015 and held it in 32 quarters.
- PFM Health Sciences's Elevance Health position peaked at $168M in Q2 2018.
- 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.
Based on PFM Health Sciences's 13F filing for Q4 2025, filed 17 Feb 2026.